PCOS: Weight loss may help improve menstrual frequency, other symptoms

Evan Walker
Evan Walker TheMediTary.Com |
A woman tying her shoe before her workoutShare on Pinterest
Scientists have found a link between weight loss interventions and PCOS symptoms. monkeybusinessimages/Getty Images
  • Polycystic ovary syndrome (PCOS) affects an estimated one in 10 women.
  • Researchers recently found that weight loss interventions may help those with PCOS reduce weight and improve blood sugar regulation and hormonal markers.
  • This work may be the first to uncover a link between weight loss interventions and a clinically significant increase in menstrual frequency.
  • The study’s authors suggest that clinicians can consult these findings to advise patients with PCOS regarding weight loss strategies.

Polycystic ovary syndrome (PCOS), also known as Stein-Leventhal Syndrome, affects women of reproductive age. It is the most common endocrine disorder and cause of infertility among women.

PCOS has no known cause or cure. Some individuals with PCOS experience few or no symptoms.

The condition often contributes to irregular or missed ovulation and menstrual periods. It may also lead to abnormally high levels of androgens, which can cause hirsutism.

Overweight or obesity affects over half of women with PCOS. At least 65% to 80% of people with PCOS live with insulin resistance as well.

Further, individuals with PCOS and excess weight tend to experience worse medical outcomes than women with PCOS and a healthier weight.

However, experts at the University of Oxford in the U.K. have found limited evidence that quantifies the effects of weight loss on PCOS symptoms. This paucity has made it difficult for practitioners to recommend specific weight loss strategies for managing PCOS.

In search of stronger confirmation, the scientists scoured through over 3,000 scientific studies. They also interviewed dozens of women with PCOS.

Their systematic review suggests that weight loss interventions have fostered “improvements in some important clinical features of PCOS.”

The study appears in the Annals of Internal Medicine.

According to clinical guidelines in the U.K., 5% weight loss could lower testosterone levels and insulin resistance markers. Health experts recommend offering women with PCOS and overweight advice on lifestyle changes, typically involving weight loss through low-carbohydrate diets and exercise.

However, this study’s patient and public involvement (PPI) advisors shared that, in their experience, support for weight management was scarce. Evidence also indicates that encouragement for weight loss with no further support is mostly ineffective.

Medical News Today discussed this study with PCOS expert Dr. Ali Chappell, PhD, MS, RD, founder and CEO of Lilli Health, who was not involved in the review.

“When interventions focus on the root cause of weight gain — insulin resistance — PCOS symptoms are more likely to improve. Directly addressing insulin resistance is essential for achieving meaningful improvements in PCOS symptoms, including weight loss,” she explained.

MNT also discussed this research with Alyssa Pacheco, RD, of The PCOS Nutritionist Alyssa, who was also not involved with the study.

“PCOS is characterized by hormonal imbalances and metabolic disturbances, [I]nsulin resistance, chronic inflammation, estrogen imbalances, high cortisol, and gut dysbiosis can all make losing weight difficult,” she said.

“When someone loses weight, they can usually expect to see improvements in blood sugar and insulin levels, cholesterol levels, and testosterone levels. It also usually means they experience less cravings and fatigue while also having more regular periods.”
— Alyssa Pacheco, RD

Pacheco also shared that individuals with PCOS are at a disproportionately higher risk of eating disorders. This, she said, calls for greater caution when discussing weight loss interventions.

Prior research suggests that low-carbohydrate interventions or pharmacotherapy can promote weight loss and greater improvements in insulin resistance, glucose, and hemoglobin markers than metformin or no intervention.

However, the University of Oxford team noticed that no reviews had compared “the full range of weight loss interventions” regarding PCOS management.

Moreover, previous studies often lacked sufficient data to analyze clinically relevant symptoms and markers for PCOS management, including menstrual frequency, hirsutism, and free androgen index (FAI).

The study’s authors searched major medical databases for randomized controlled trials (RCTs) from inception until June 2024. They focused on RCTs of interventions to reduce weight in adults diagnosed with PCOS.

The experts compared:

  • “usual care” of metformin, oral contraceptives, and standard advice,
  • “minimal intervention” such as advice for losing weight without further support, or
  • placebos.

They also analyzed trials that compared lower and higher-intensity weight loss interventions.

Primary outcomes

The review’s primary outcomes comprised of symptoms and biological markers of PCOS. They were chosen in consultation with clinicians with expertise in PCOS and 36 individuals with PCOS.

Included RCTs contained data that allowed weight change calculations and at least one symptom or bio marker of PCOS such as fasting insulin, fasting glucose, testosterone, FAI, menses frequency, acne, and hirsutism.

The study’s researchers started with 3,760 studies, paring their list down to 39. Over 1,500 people contributed data to the primary analyses, and over 2,300 contributed data to the secondary analyses.

Chappell believes that the study’s findings highlight the importance of targeting insulin resistance to improve PCOS symptoms.

She also noted that while caloric restriction and other weight loss interventions resulted in modest weight loss, “they often failed to improve sex hormone levels and related PCOS symptoms such as hirsutism.”

“Insulin is the primary driver of androgen secretion and related PCOS symptoms, which is not influenced by calorie restriction alone,” she said.

Overall, the University of Oxford researchers feel that their work offers helpful considerations for individuals living with PCOS and overweight and their healthcare providers: “Weight loss interventions were associated with improvements in some important features of PCOS and should be considered as a routine treatment option for people with PCOS.”

Share this Article